Company news
Helix BioPharma Corp. news in 2005
Helix BioPharma Corp.'s news releases, calls and decks from 2005, newest first.
Helix BioPharma signs L-DOS47 manufacturing agreement with QSV Biologics
December 19, 2005
Helix BioPharma announces Q1 2006 financial results
December 15, 2005
Helix closes $5.5 million private placement
November 7, 2005
Helix BioPharma Corp. announces fiscal 2005 results
October 31, 2005
DOS47 scientific paper published in the Journal of Experimental Therapeutics and Oncology
October 24, 2005
Helix closes $4 million private placement
October 4, 2005
Helix receives approval to conduct a clinical trial of Topical Interferon Alpha-2b in Sweden
September 12, 2005
Helix announces appointment of new Chief Financial Officer; Announces 3rd quarter fiscal 2005 financial results and provides development update
June 14, 2005
Helix opens additional sites for its Topical Interferon Alpha-2b Phase II clinical study
June 2, 2005
Helix identifies lead product candidate from DOS47 cancer therapeutic program
May 2, 2005